Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Acetylsalicylic acid
Alliance Pharma (Ireland) Limited
N02BA; N02BA01
Acetylsalicylic acid
300 milligram(s)
Gastro-resistant tablet
Salicylic acid and derivatives; acetylsalicylic acid
Marketed
1998-04-01
Nu-Seals 300 PIL ROI 015 PATIENT INFORMATION LEAFLET NU-SEALS ® 300MG GASTRO-RESISTANT TABLETS aspirin (acetylsalicylic acid) READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. WHAT NU-SEALS 300MG IS AND WHAT IT IS TAKEN FOR 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE NU-SEALS 300MG 3. HOW TO TAKE NU-SEALS 300MG 4. POSSIBLE SIDE EFFECTS 5. HOW TO STORE NU-SEALS 300MG 6. CONTENTS OF THE PACK AND OTHER INFORMATION 1. WHAT NU-SEALS 300MG IS AND WHAT IT IS TAKEN FOR Nu-Seals 300mg contains aspirin. Aspirin is used: as an anti-inflammatory analgesic which can relieve pain and swelling to bring down high body temperatures to prevent recurrence of heart attacks or strokes by thinning the blood. If someone who has previously had a heart attack or stroke takes Nu-Seals 300mg regularly, it reduces the risk of a blood clot occurring in the heart or brain. This can prevent further heart attacks or strokes. IF YOU TAKE ASPIRIN IN HIGH DOSES OR OVER A LONG PERIOD OF TIME, IT CAN IRRITATE YOUR STOMACH LINING. TO PREVENT STOMACH IRRITATION, THESE TABLETS HAVE A SPECIAL COATING (CALLED ENTERIC) SO THAT THE ASPIRIN IS NOT RELEASED UNTIL IT HAS PASSED THROUGH THE STOMACH. Aspirin is released slowly from these tablets, so Nu-Seals 300mg is not suitable for the short-term relief of pain, such as headaches or toothache. Nu-Seals 300 PIL ROI 015 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE NU-SEALS 300MG DO NOT TAKE NU-SEALS 300MG: if you are allergic to aspirin or any of the other ingredients in this medici Read the complete document
Health Products Regulatory Authority 07 February 2020 CRN009LFK Page 1 of 8 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Nu-Seals 300 mg Gastro-resistant Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains: Acetylsalicylic Acid Ph. Eur. (Aspirin) 300 mg. For a full list of excipients see section 6.1. 3 PHARMACEUTICAL FORM Gastro-resistant tablet. Gastro-resistant tablets, white in colour, printed with ‘300’ in red. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Aspirin has analgesic, antipyretic and anti-inflammatory actions. It also has an anti-thrombotic action, mediated through inhibition of platelet activation, which has been shown to be useful in secondary prophylaxis following myocardial infarction, and in patients with unstable angina or ischaemic stroke. Nu-Seals 300 is indicated wherever high and prolonged dosage of aspirin is required. The special coating resists dissolution in gastric juice, but will dissolve readily in the relatively less acid environment of the duodenum. Owing to the delay that the coating imposes on the release of the active ingredient, Nu-Seals 300 is unsuitable for the short-term relief of pain. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Nu-Seals 300 is for oral administration to adults only. _Analgesic, antipyretic and anti-inflammatory actions_: The usual dose of aspirin is 300-900mg repeated three to four times daily according to clinical needs. In acute rheumatic disorders the dose is in the range of 4-8 g daily, taken in divided doses. _Antithrombotic action_: For its antithrombotic effect following myocardial infarction, ischaemic stroke and in patients with unstable angina, the recommended dose is 300mg daily. _The Elderly:_ As for adults. Aspirin should be used with particular caution in elderly patients who are more prone to adverse events. Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms (see section 4.4). Treatment should be reviewed at regular Read the complete document